Table 1.

Number of US adults aged ≥18 years beginning treatment for diabetes-related end-stage kidney disease, by race or ethnicity,^* sex, age, and treatment modality, 2000 and 2016.

	AIANs		Asians		Blacks		Whites		Hispanics
	2000	2016	2000	2016	2000	2016	2000	2016	2000	2016
	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)	N (%)
Total	878	825	1,141	2,618	11,355	13,742	27,306	38,794	6,897	10,187
Sex
Male	397	440	602	1,546	4,800	7,054	14,282	22,755	3,451	5,890
	(45.2)	(53.3)	(52.8)	(59.1)	(42.3)	(51.3)	(52.3)	(58.7)	(50.0)	(57.8)
Female	481	385	539	1,072	6,555	6,688	13,024	16,039	3,446	4,297
	(54.8)	(46.7)	(47.2)	(40.9)	(57.7)	(48.7)	(47.7)	(41.3)	(50.0)	(42.2)
Age (years)
18–44	88	124	61	156	1,195	1,741	2,644	2,776	640	1,053
	(10.0)	(15.0)	(5.3)	(6.0)	(10.5)	(12.7)	(9.7)	(7.2)	(9.3)	(10.3)
45–64	514	422	438	944	5,450	6,294	10,848	15,665	3,372	4,927
	(58.5)	(51.2)	(38.4)	(36.1)	(48.0)	(45.8)	(39.7)	(40.4)	(48.9)	(48.4)
65–74	210	205	384	789	3,086	3,639	8,214	12,161	1,924	2,667
	(23.9)	(24.8)	(33.7)	(30.1)	(27.2)	(26.5)	(30.1)	(31.3)	(27.9)	(26.2)
≥75	66	74	258	729	1,624	2,068	5,600	8,192	961	1,540
	(7.5)	(9.0)	(22.6)	(27.8)	(14.3)	(15.0)	(20.5)	(21.1)	(13.9)	(15.1)
Treatment modality
Hemodialysis	802	754	1,030	2,241	10,698	12,689	24,361	34,800	6,413	9,290
	(91.3)	(91.4)	(90.3)	(85.6)	(94.2)	(92.3)	(89.2)	(89.7)	(93.0)	(91.2)
Peritoneal dialysis	70	68	97	356	586	1,000	2,457	3,636	433	845
	(8.0)	(8.2)	(8.5)	(13.6)	(5.2)	(7.3)	(9.0)	(9.4)	(6.3)	(8.3)
Transplant	NA†	NA†	NA†	20	22	48	299	318	17	46
				(0.8)	(0.2)	(0.3)	(1.1)	(0.8)	(0.2)	(0.5)
Unknown	NA†	NA†	NA†	--†	49	--†	189	40	34	--†
					(0.4)		(0.7)	(0.1)	(0.5)

^*Racial groups include people of Hispanic and non-Hispanic origin; Hispanics may be of any race.

^†Cell size ≤10.

AIANs=American Indians and Alaska Natives; NA=not available.